ACB $15.141 (-3%)

ACNNF $0.120 (0%)

AERO $2.695 (-0.19%)

AGEEF $0.072 (-2.04%)

ALEAF $0.456 (-3.7%)

AMMJ $0.204 (-12.66%)

APHA $4.106 (-2.71%)

ARNA $56.910 (-3.4%)

ATT:CNX $0.080 (0%)

ATTBF $0.010 (15.15%)

AUSA:CNX $0.295 (3.51%)

AUSAF $0.200 (10.62%)

AVXL $4.090 (-3.54%)

BAMM:CNX $0.530 (0%)

BBM:CNX $0.075 (0%)

BBRRF $0.056 (1.46%)

BE:CNX $0.015 (50%)

BIO:CNX $0.115 (9.52%)

BLEVF $0.015 (150%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.450 (2.27%)

BLOZF $0.340 (10.93%)

BUDZ $0.460 (-4.17%)

BXNG $0.720 (2.86%)

CADMF $0.618 (3.3%)

CALI:CNX $0.080 (0%)

CANN $0.530 (0%)

CARA $16.310 (-0.91%)

CBII:CNX $0.140 (0%)

CBIIF $0.103 (2.7%)

CBWTF $0.313 (4.05%)

CGC $19.470 (-2.7%)

CGRW $0.135 (14.68%)

CHOO:CNX $0.130 (0%)

CHOOF $0.092 (15.49%)

CNBX $0.275 (7.63%)

CNGGF $0.620 (0%)

CODI $17.110 (0.82%)

CPMD $1.400 (2.19%)

CRBP $8.010 (-0.62%)

CRON $6.660 (-0.6%)

CROP:CNX $0.015 (0%)

CRTPF $1.799 (-1.18%)

CRXPF $0.024 (-3.03%)

CSI:CNX $0.810 (-5.81%)

CURR $2.126 (-7.57%)

CVSI $1.180 (25.53%)

DIGP $0.041 (-9.76%)

DXBRF $0.140 (0%)

EAPH $0.001 (18.18%)

EAT:CNX $0.030 (0%)

EEVVF $0.062 (-26.46%)

EMHTF $0.170 (6.71%)

EPWCF $0.050 (2.04%)

EVIO $0.024 (16.59%)

FFRMF $0.022 (10%)

FFT:CNX $0.030 (20%)

FNNZF $0.066 (2.98%)

GGTTF $0.130 (22.76%)

GLDFF $0.015 (-17.22%)

GLH:CNX $0.020 (0%)

GNBT $0.680 (-10.23%)

GRIN:CNX $0.115 (4.55%)

GRWG $6.430 (-3.45%)

GSTR:CNX $0.050 (42.86%)

GTBIF $9.830 (1.84%)

GTII:CNX $13.570 (0.22%)

GWPH $131.150 (3.33%)

HEXO $0.646 (-6.91%)

HHPHF $0.016 (0%)

HLSPY $0.460 (-7.98%)

HMLSF $5.826 (1.93%)

HMPPF $0.498 (0%)

HRVOF $0.093 (-2.21%)

HSTRF $0.075 (-0.66%)

HUGE:CNX $4.380 (-0.45%)

IAN:CNX $0.520 (11.83%)

IGC $0.579 (-1.92%)

IGXT $0.220 (2.49%)

IIPR $83.995 (-1.18%)

IMLFF $0.217 (0.14%)

INQD $0.002 (41.67%)

IONC:CNX $0.020 (-20%)

IONKF $0.016 (6.9%)

ISOL:CNX $0.065 (-7.14%)

ISOLF $0.052 (-30.71%)

ITHUF $0.340 (39.77%)

IVITF $0.040 (-3.03%)

JWCAF $0.010 (-33.33%)

KALTF $0.021 (41.06%)

KBEV:CNX $0.090 (-5.26%)

KBEVF $0.073 (16.8%)

KHRNF $0.575 (0.23%)

KSHB $1.030 (16.38%)

LHS:CNX $0.500 (-9.09%)

LHSIF $0.400 (4.63%)

LOVE:CNX $0.110 (0%)

LXRP $0.388 (18.14%)

LXX:CNX $0.480 (-7.69%)

MCIG $0.029 (0%)

MEDIF $1.390 (0%)

MGWFF $0.049 (-2%)

MICWF $0.058 (0%)

MJ:CNX $0.050 (0%)

MJNA $0.030 (42.86%)

MNTR $0.170 (54.5%)

MRRCF $0.006 (0%)

MWM:CNX $0.205 (0%)

MYM:CNX $0.080 (0%)

MYMMF $0.058 (-20.44%)

NCNNF $0.178 (-10.9%)

NDVAF $0.247 (-5.36%)

NGW:CNX $0.120 (0%)

NRXCF $0.045 (0%)

NSPDF $0.046 (10.6%)

NTEC $0.278 (-0.71%)

NVTQF $0.098 (0%)

NWKRF $0.424 (0%)

NXGWF $0.085 (-10.42%)

NXTTF $0.317 (14.65%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.010 (-7.36%)

PHVAF $0.070 (32.08%)

PILL:CNX $0.930 (1.09%)

PKG:CNX $0.125 (-7.41%)

PLPRF $0.630 (11.1%)

PLUS:CNX $0.870 (1.16%)

PMCB $0.020 (1.52%)

PNPL $0.600 (990.91%)

POTN $0.017 (0.59%)

PRCNF $0.010 (-23.08%)

PTNYF $0.100 (42.24%)

QCA:CNX $0.105 (0%)

RDDTF $0.130 (-3.42%)

RLLVF $0.028 (22.27%)

RMHB $0.022 (-2.27%)

RQB:CNX $0.005 (0%)

RQHTF $0.294 (18.95%)

RVVQF $0.005 (3.9%)

SLNG:CNX $0.240 (-4%)

SMG $138.065 (2.54%)

SNN:CNX $0.130 (-3.7%)

SNNVF $0.100 (5.88%)

SOL:CNX $0.540 (-5.26%)

SOLCF $0.421 (10.66%)

SPLIF $0.025 (-15.25%)

SPRWF $0.272 (19.78%)

SRNA $0.031 (-7.13%)

STEM:CNX $0.630 (-1.56%)

STMH $0.430 (-10.42%)

SUN:CNX $0.195 (0%)

TBPMF $0.172 (2.62%)

TCAN:CNX $0.940 (-6%)

TCNAF $0.730 (-8.88%)

TER:CNX $2.830 (-4.07%)

TGEN $0.858 (-1.89%)

TGIF:CNX $0.100 (17.65%)

TGIFF $0.062 (-6.06%)

THC:CNX $0.140 (-6.67%)

THCBF $0.111 (38.03%)

TLRY $10.810 (5.36%)

TOKI:CNX $0.045 (0%)

TRLFF $0.032 (-21.09%)

TRPX $0.510 (18.6%)

TRSSF $2.147 (6.27%)

TRTC $0.126 (-5.26%)

TURV $0.085 (-2.3%)

VBIO $0.060 (1.87%)

VIDA:CNX $0.085 (-5.56%)

VIN:CNX $0.025 (-16.67%)

VPRB $0.011 (0%)

VRNDF $0.430 (14.33%)

VRT:CNX $0.165 (6.45%)

VRTHF $0.111 (-6.59%)

VVCIF $0.201 (15.1%)

WAYL:CNX $0.740 (0%)

WDDMF $0.479 (9.73%)

WLDFF $0.147 (-3.03%)

XXII $0.840 (-1.25%)

ZDPY $0.145 (0%)

ZYNE $6.190 (-4.48%)

Back

Auxly Announces Receipt of Sales Licence for Premium Craft Cannabis Brand Robinsons

May 20, 2020 • 7:44 AM EDT
5 MIN READ  •  By Anthony Varrell
Share Share - Facebook Share - Twitter

Auxly Cannabis Group Inc. (TSX.V – XLY), a consumer packaged goods company in the cannabis products market, is pleased to announce that its wholly owned subsidiary Robinsons Cannabis Inc. has been authorized by Health Canada to sell dried cannabis to provinces and territories under the Cannabis Regulations. This sales licence expands Auxly’s product portfolio to include artisan hand-crafted cannabis flower for the premium craft market, which the Company expects to be available in select Canadian provinces this summer.

“We couldn’t be more excited to obtain this sales licence for Robinsons – a key milestone for Auxly as we continue to execute against our vision of being a leader in branded cannabis products,” said Hugo Alves, CEO of Auxly. “Congratulations to the talented team at Robinsons who are growing what I believe is the best cannabis in Canada, and special thanks to Health Canada for their ability to facilitate this licence in the midst of unique challenges presented by the COVID-19 pandemic.”

Since obtaining the initial cultivation licence, Robinsons has been growing small-batch premium cannabis at its 27,700 sq. ft. state-of-the-art facility in Kentville, Nova Scotia. Robinsons’ cultivation methodologies are premised on an uncompromising commitment to quality and craftsmanship, all overseen by Founder and Master Grower Andrew Robinson. Robinsons’ focus on quality and flavour results in a uniquely premium product for the cannabis connoisseur. For more information about Robinsons, go to robinsonscannabis.com.

ON BEHALF OF THE BOARD

Hugo Alves CEO

About Auxly Cannabis Group Inc. (TSX.V: XLY)

Auxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:
For investor enquiries please contact our Investor Relations Team:
Email: IR@auxly.com
Phone: 1.833.695.2414

Media Enquiries (only): 
For media enquiries or to set up an interview please contact:
Email: press@auxly.com

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the proposed operation of the Robinsons facility; the successful production and launch of Robinsons products; the Company’s execution of its product development and commercialization strategy; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: Robinsons is able to maintain its sales licence and is able to obtain and maintain all other necessary governmental and regulatory authorizations and permits to conduct business; the acceptance and demand for Robinsons products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2019 dated May 13, 2020.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on Auxly’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. The purpose of forward-looking information is to provide the reader with a description of management’s expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this release.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, Auxly does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

Primary Logo

 

Source: GlobeNewswire (May 20, 2020 – 7:30 AM EDT)

News by QuoteMedia
www.quotemedia.com

Share Share - Facebook Share - Twitter

Tags

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Technical420 newsletter.

 All good -- no spamming here.